BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5612658)

  • 1. [Experiences with an internal treatment method in inflammatory and ulcerative disorders of the gastric and intestinal mucosa].
    Zwerenz G
    Landarzt; 1967 Oct; 43(29):1431-3. PubMed ID: 5612658
    [No Abstract]   [Full Text] [Related]  

  • 2. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with Medazepam in gestrointestinal diseases].
    Venhofen JM; Weiss D
    Arzneimittelforschung; 1968 Dec; 18(12):1569-70. PubMed ID: 5756252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of xylamide on the gastric and duodenal mucosa].
    Galeone M; Fichera G
    Minerva Gastroenterol; 1972; 18(4):183-9. PubMed ID: 4680178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on the use of phentonium in hypersecretive and ulcerative gastroduodenal diseases].
    Azzollini F; Fichera G
    Clin Ter; 1972 Nov; 63(3):259-67. PubMed ID: 4644530
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of gastritis and gastro-duodenal ulcers with drugs with predominantly spasmolytic and vasodilating action].
    Cascone A; Ferrari F
    Minerva Gastroenterol; 1969; 15(2):60-77. PubMed ID: 4389365
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Data on the therapeutic use of vitamin U].
    Varga D
    Ter Arkh; 1974; 46(4):84-9. PubMed ID: 4428375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local treatment of non-healing gastroduodenal ulcers with solcoseryl].
    Kan Ch; Saidmuradova A; Kravchenko LIa; Mishanina ZG
    Klin Med (Mosk); 1988 Jan; 66(1):81-4. PubMed ID: 3361822
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.
    Johansson C; Kollberg B
    Scand J Gastroenterol Suppl; 1980; 58():93-7. PubMed ID: 6988944
    [No Abstract]   [Full Text] [Related]  

  • 11. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the pathogenesis and treatment of erosive gastritis and duodenitis].
    Vakhrushev IaM; Nikishina EV
    Klin Med (Mosk); 1999; 77(2):28-31. PubMed ID: 10380457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of peptic ulcer patients with pantothenic acid].
    Mochalkin NI
    Vrach Delo; 1966 Aug; 8():115-6. PubMed ID: 5989128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of mucosal protection of peptic ulceration and its clinical therapeutic application].
    Novis B; Samara M
    Harefuah; 1984 Nov; 107(10):308-10. PubMed ID: 6530177
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of halidor on the various pathologic processes of the gastrointestinal mucous membrane.
    Dvorský A
    Ther Hung; 1968; 16(1):21-7. PubMed ID: 5651017
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Ito M; Tanaka S; Kawamura Y; Chayama K; Haruma K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():99-104. PubMed ID: 15943855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins, gastroduodenal ulcer and hemorrhagic gastritis.
    Bright-Asare P; Whiten JT
    Clin Physiol Biochem; 1984; 2(2-3):101-10. PubMed ID: 6333308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs, gastritis, and peptic ulcer.
    Ivey KJ
    J Clin Gastroenterol; 1981; 3(Suppl 2):29-34. PubMed ID: 7320467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
    Danelius M; Ost A; Lapidus AB
    Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcers and gastritis.
    Pang SH; Leung WK; Graham DY
    Endoscopy; 2008 Feb; 40(2):136-9. PubMed ID: 18058616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.